{"id":"doi:10.1056/nejmoa1701488","kind":"article","title":"Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients","authors":["Paul M. Ridker","James H. Revkin","Pierre Amarenco","Robert Brunell","Madelyn Curto","Fernando Civeira","Marcus D Flather","Robert J. Glynn","Jean C. Grégoire","J. Wouter Jukema","Yuri Karpov","John J.P. Kastelein","Wolfgang Köenig","Alberto J. Lorenzatti","Pravin Manga","URSZULA S. MASIUKIEWICZ","Michael J. Miller","Arend Mosterd","Ján Murín","José Carlos Nicolau","Steven E. Nissen","Piotr P. Ponikowski","Raul Dias Santos","Pamela F. Schwartz","Handrean Soran"],"author_count":31,"year":2017,"published":"2017-03-17","venue":"New England Journal of Medicine","cited_by":624,"doi":"10.1056/nejmoa1701488","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa1701488","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa1701488","updated":null,"pmid":"28304242","pmcid":null,"openalex_id":"W2596236174","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488?articleTools=true","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}